Insider Selling: Fennec Pharmaceuticals Inc. (TSE:FRX) Director Sells C$23,190.58 in Stock

Fennec Pharmaceuticals Inc. (TSE:FRX – Get Free Report) Director Chris Anigeron Rallis sold 2,114 shares of the company’s stock in a transaction that occurred on Tuesday, March 26th. The shares were sold at an average price of C$10.97, for a total value of C$23,190.58. Fennec Pharmaceuticals Stock Up 2.0 % Shares of FRX opened at […]

Leave a Reply

Your email address will not be published.

Previous post GraniteShares 1.25X Long TSLA Daily ETF (NASDAQ:TSL) Short Interest Update
Next post State of Alaska Department of Revenue Has $6.05 Million Holdings in CubeSmart (NYSE:CUBE)